BIOCRYST PHARMACEUTICALS INC (BCRX) › RevenueBIOCRYST PHARMACEUTICALS INC (BCRX) — RevenueAnnual figures by period end, from SEC filings.2016-12-31: $26.35M2017-12-31: $25.19M2018-12-31: $20.65M2019-12-31: $48.84M2020-12-31: $17.81M2021-12-31: $157.17M2022-12-31: $270.83M2023-12-31: $331.41M2024-12-31: $450.71M2025-12-31: $874.84M$874.84M2016-12-31Revenue (USD)2025-12-31Period endedRevenueChange YoYSource filing2025-12-31$874.84M+94.1%2026-02-26From 2025-01-012024-12-31$450.71M+36.0%2026-02-26From 2024-01-012023-12-31$331.41M+22.4%2026-02-26From 2023-01-012022-12-31$270.83M+72.3%2025-02-25From 2022-01-012021-12-31$157.17M+782.4%2024-02-27From 2021-01-012020-12-31$17.81M-63.5%2023-02-27From 2020-01-012019-12-31$48.84M+136.5%2022-02-28From 2019-01-012018-12-31$20.65M-18.0%2021-03-01From 2018-01-012017-12-31$25.19M-4.4%2020-03-13From 2017-01-012016-12-31$26.35M—2019-03-14From 2016-01-01Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)